T2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024
T2 Biosystems (NASDAQ:TTOO), a leader in rapid sepsis pathogen and antibiotic resistance gene detection, has announced its second quarter 2024 financial results and business updates will be reported on July 29, 2024, after market close. The company will host a conference call at 4:30 p.m. Eastern Time on the same day.
Investors can access the call by dialing 1-888-506-0062 (US/Canada) or 1-973-528-0011 (International) with passcode 109834. A live and archived webcast will also be available on the company's website in the Investors section under Events & Presentations.
T2 Biosystems (NASDAQ:TTOO), leader nella rapida identificazione di patogeni da sepsi e geni di resistenza agli antibiotici, ha annunciato che i risultati finanziari del secondo trimestre 2024 e gli aggiornamenti aziendali saranno riportati il 29 luglio 2024, dopo la chiusura del mercato. L'azienda condurrà una conferenza telefonica alle 16:30 ora orientale dello stesso giorno.
Gli investitori possono partecipare alla chiamata componendo il numero 1-888-506-0062 (USA/Canada) o 1-973-528-0011 (Internazionale) con il codice di accesso 109834. Sarà disponibile anche una webcomunità dal vivo e registrata sul sito web dell'azienda nella sezione Investitori sotto Eventi e Presentazioni.
T2 Biosystems (NASDAQ:TTOO), líder en la detección rápida de patógenos por sepsis y genes de resistencia a los antibióticos, ha Anunciado que los resultados financieros del segundo trimestre de 2024 y las actualizaciones comerciales se informarán el 29 de julio de 2024, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica a las 4:30 p.m. hora del Este el mismo día.
Los inversores pueden acceder a la llamada marcando 1-888-506-0062 (EE.UU./Canadá) o 1-973-528-0011 (Internacional) con el código de acceso 109834. También estará disponible una retransmisión en vivo y grabada en el sitio web de la empresa en la sección de Inversores bajo Eventos y Presentaciones.
T2 바이오시스템즈 (NASDAQ:TTOO)는 패혈증 병원체 및 항생제 내성 유전자 신속 탐지의 선두주자로서 2024년 2분기 재무 결과 및 비즈니스 업데이트를 2024년 7월 29일 시장 마감 후 발표할 것이라고 알렸습니다. 회사는 같은 날 동부 표준시 오후 4시 30분에 컨퍼런스 콜을 진행할 예정입니다.
투자자들은 1-888-506-0062 (미국/캐나다) 또는 1-973-528-0011 (국제)로 전화하여 비밀번호 109834를 입력하여 콜에 참여할 수 있습니다. 또한, 회사의 웹사이트 투자자 섹션 내 이벤트 및 프레젠테이션에서 실시간 및 녹화된 웹캐스트도 제공될 예정입니다.
T2 Biosystems (NASDAQ:TTOO), leader dans la détection rapide des agents pathogènes de sepsis et des gènes de résistance aux antibiotiques, a annoncé que les résultats financiers du deuxième trimestre 2024 et les mises à jour commerciales seront publiés le 29 juillet 2024, après la clôture du marché. L'entreprise tiendra une conférence téléphonique à 16h30 heure de l'Est le même jour.
Les investisseurs peuvent accéder à l'appel en composant le 1-888-506-0062 (États-Unis/Canada) ou le 1-973-528-0011 (International) avec le code d'accès 109834. Un webinaire en direct et enregistré sera également disponible sur le site de l'entreprise dans la section Investisseurs sous Événements & Présentations.
T2 Biosystems (NASDAQ:TTOO), ein führendes Unternehmen in der schnellen Erkennung von Sepsispathogenen und Antibio-resistenzgenen, hat bekannt gegeben, dass die finanziellen Ergebnisse des zweiten Quartals 2024 und Unternehmensupdates am 29. Juli 2024, nach Markt-schluss veröffentlicht werden. Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten.
Investoren können an dem Anruf teilnehmen, indem sie 1-888-506-0062 (USA/Kanada) oder 1-973-528-0011 (International) anrufen und den Zugangscode 109834 eingeben. Außerdem wird eine Live- und Archivübertragung auf der Website des Unternehmens im Bereich Investoren unter Veranstaltungen & Präsentationen verfügbar sein.
- None.
- None.
LEXINGTON, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the second quarter 2024 and business updates after market close on Monday, July 29, 2024.
Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.t2biosystems.com, on the Investors page in the Events & Presentations section. To listen to the conference call, please dial 1-888-506-0062 (US/Canada) or 1-973-528-0011 (International), passcode 109834, approximately ten to five minutes prior to the start time.
About T2 Biosystems
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, the T2Bacteria® Panel, the T2Candida® Panel, the T2Resistance® Panel, and the T2Biothreat™ Panel, and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the U.S. T2Resistance Panel, the Candida auris test, and the T2Lyme™ Panel. For more information, please visit www.t2biosystems.com.
Investor Contact:
Philip Trip Taylor, Gilmartin Group
ir@T2Biosystems.com
415-937-5406
FAQ
When will T2 Biosystems (TTOO) report its Q2 2024 financial results?
How can investors listen to T2 Biosystems' (TTOO) Q2 2024 earnings call?
What time is T2 Biosystems' (TTOO) Q2 2024 earnings conference call?
Where can I find the webcast for T2 Biosystems' (TTOO) Q2 2024 earnings call?
